MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Fentanyl Induced Chorea: A Case Report

    M. Gallagher, A. Colcher, A. McGarry (Camden, NJ, USA)

    Objective: To report the acute onset of generalized chorea as an adverse reaction to transdermal fentanyl Background: Chorea can present with degenerative conditions or in an…
  • 2017 International Congress

    Cholinergic activity, mobility, and attention in mild cognitive impairment

    D. Martini, K. Smulders, A. Hiller, K. Chung, J. Quinn, F. Horak (Portland, OR, USA)

    Objective: The aim of this investigation is to relate cholinergic activity (CA) to objective measures of balance, gait, and attention in a MCI and control…
  • 2017 International Congress

    Axial Myoclonus in a Patient with PSP

    R. Passo, T. Clark (Portland, OR, USA)

    Objective: This is a case report from the Portland VA Medical Center. Background: PSP is a parkinsonian neurodegenerative disorder characterized by deposition of tau in…
  • 2017 International Congress

    Structural brain changes in patients with Multi System Atrophy: A VBM and DTI based study.

    J. Saini, P. Pal, L. George, S. Dash (Bangalore, India)

    Objective: To evaluate the grey matter (GM) and white matter (WM) changes in patients with Multiple System Atrophy (MSA) using MRI.   Background: MSA is a…
  • 2017 International Congress

    Loss of PDE10A expression in patients with PDE10A and ADYC5 mutations

    F. Niccolini, N. Mencacci, E. Rabiner, V. Salpietro, G. Pagano, B. Balint, H. Houlden, R. Gunn, N. Wood, K. Bhatia, M. Politis (London, United Kingdom)

    Objective: To assess phosphodiesterase 10A (PDE10A) expression in vivo, using [11C]IMA107 PET in patients with PDE10A and adenylate cyclase 5 (ADYC5) mutations. Background: Cyclic adenosine…
  • 2017 International Congress

    The highly-selective metabotropic glutamate receptor 2 positive allosteric modulator LY-487,379 alleviates psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset

    L. Sid-Otmane, S. Nuara, A. Hamadjida, N. Veyres, C. Rouillard, M. Panisset, J. Gourdon, P. Huot (Montreal, QC, Canada)

    Objective: To investigate the effect of metabotropic glutamate receptor 2 (mGluR2) activation on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced psychosis-like behaviours (PLBs) and dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset…
  • 2017 International Congress

    Network for parallel gamma synchronizations during upper limb movement

    G. Tamas, A. Anwar, G. Deuschl, J. Raethjen, S. Groppa, M. Muthuraman (Budapest, Hungary)

    Objective: Our aim was to identify the sources of parallel gamma synchronizations (GS) and analyze the direction of information flow in their network, at the…
  • 2017 International Congress

    Risk Factors for Dementia in Parkinson’s disease

    M.I. Khalil, M.R. Rahman, S. Munira (Dhaka, Bangladesh)

    Objective: To investigate putative risk factors for the development of dementia in patients with Parkinson’s disease. Background: Dementia in idiopathic Parkinson’s disease (PD) is a…
  • 2017 International Congress

    Action Verb Generation as a marker of cognitive function in Parkinson disease

    O. Yerokhin, K. Smith (Worcester, MA, USA)

    Objective: We investigated action-verb generation in relation to cognitive function and motor severity in patients with Parkinson disease (PD). Background: PD causes speech and language…
  • 2017 International Congress

    IGF-1 levels are associated with CSF pathology and executive dysfunction in de novo Parkinson’s disease patients

    G. Dervenoulas, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To investigate whether serum insulin-like growth factor-1 (IGF-1) is associated with clinical-neuropsychiatric, imaging and CSF markers of PD pathology in patients with early, drug-naïve…
  • 1
  • 2
  • 3
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley